WuXi PharmaTech (Cayman) Inc. Stock-Based Compensation
WuXi PharmaTech (Cayman) Inc. reported Stock-Based Compensation of $22.96 million for the 12-month period ending 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2015-04-15
| Period end | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|
| 2014-12-31 | $22.96M 20-F · filed 2015-04-15 | |
| 2013-12-31 | $17.89M 20-F · filed 2015-04-15 | $17.88M 20-F · filed 2014-04-15 |
| 2012-12-31 | $14.31M 20-F · filed 2015-04-15 | |
| 2011-12-31 | $11.47M 20-F · filed 2014-04-15 | |
| 2010-12-31 | $10.09M 20-F · filed 2013-04-17 | |
| 2009-12-31 | $10.22M 20-F · filed 2012-04-20 | |
| 2008-12-31 | $13.05M 20-F · filed 2011-04-27 |